Evidence map›Paper›PMID 21239431›Full record

ArticleEndocrinology2011

In vivo activity of the thyroid hormone receptor beta- and α-selective agonists GC-24 and CO23 on rat liver, heart, and brain.

Carmen Grijota-Martínez, Eric Samarut, Thomas S Scanlan, Beatriz Morte, Juan Bernal

Open access · bronzeAbstract read
In one paragraph

Article in Endocrinology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Thyroid hormone regulation of metabolism.Physiological reviews · 2014
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Carmen Grijota-MartínezInstituto de Investigaciones Biomédicas, Consejo Superior de Investigaciones Científicas and Universidad Autónoma de Madrid, 28029 Madrid, Spain.
Eric Samarut
Thomas S Scanlan
Beatriz Morte
Juan Bernal
Centre for Biomedical Network Research on Rare Diseases · ESConsejo Superior de Investigaciones Científicas · ESOregon Health & Science University · USUniversidad Autónoma de Madrid · ES

Funding

Thyroid Hormone ActionR01DK052798 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SCANLAN, THOMAS STERLING · 1997 to 2020
$5.7M
Thyroid Hormone ActionR56DK052798 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI SCANLAN, THOMAS STERLING · 2009 to 2021
$581k
NIDDK NIH HHS DK-52798NIDDK NIH HHS R01 DK052798NIDDK NIH HHS R56 DK052798
6 · The paper itself

Abstract

Thyroid hormone analogs with selective actions through specific thyroid hormone receptor (TR) subtypes are of great interest. They might offer the possibility of mimicking physiological actions of thyroid hormone with receptor subtype or tissue specificity with therapeutic aims. They are also pharmacological tools to dissect biochemical pathways mediated by specific receptor subtypes, in a complementary way to mouse genetic modifications. In this work, we studied the in vivo activity in developing rats of two thyroid hormone agonists, the TRβ-selective GC-24 and the TRα-selective CO23. Our principal goal was to check whether these compounds were active in the rat brain. Analog activity was assessed by measuring the expression of thyroid hormone target genes in liver, heart, and brain, after administration to hypothyroid rats. GC-24 was very selective for TRβ and lacked activity on the brain. On the other hand, CO23 was active in liver, heart, and brain on genes regulated by either TRα or TRβ. This compound, previously shown to be TRα-selective in tadpoles, displayed no selectivity in the rat in vivo.

Indexed as

AcetatesAnimalsBenzhydryl CompoundsBrainGene Expression RegulationHeartHydantoinsHypothyroidismLiverRatsRats, WistarThyroid Hormone Receptors alphaThyroid Hormone Receptors betaTriiodothyronine5-(3,5-diiodo-4-(3-isopropyl-4-hydroxyphenoxy)benzyl)imidazolidine-2,4-dioneAcetatesBenzhydryl CompoundsGC 24 compoundHydantoinsThyroid Hormone Receptors alphaThyroid Hormone Receptors betaTriiodothyronine

Identifiers

PMID21239431
PMCPMC3040061
OpenAlexW2033340209

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.